表紙
市場調査レポート

組織工学向け医療用品の世界市場:予測と機会 (2020年)

Global Tissue Engineered Medical Devices Market Forecast and Opportunities, 2020

発行 Pharmaion 商品コード 346833
出版日 ページ情報 英文 193 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.75円で換算しております。
Back to Top
組織工学向け医療用品の世界市場:予測と機会 (2020年) Global Tissue Engineered Medical Devices Market Forecast and Opportunities, 2020
出版日: 2015年12月11日 ページ情報: 英文 193 Pages
概要

組織工学とは、生きている人体の内部の完全に機能している組織・臓器に、細胞・骨格・生物学的活性分子を組み込むための、バイオマテリアルの開発と実際の組み込み過程とを指し、機能不全となった組織・臓器を代替を目的としています。組織工学向け医療用品は、人造インプラントと比べて生物的適合性が高く、医師に好まれています。更に、人体の自己免疫反応が発生する確率も低くなっています。世界の組織工学向け医療用品の市場は、2020年には260億米ドル以上の規模に達すると推計されています。

当レポートでは、世界の組織工学向け医療用品の市場について分析し、全体的な市場規模・シェアの動向見通し (通算11年間分) や、分野別・地域別の詳細動向、主要企業のプロファイル、市場構造の変化と新たな市場機会、関係者への提言といった内容を取りまとめてお届けいたします。

第1章 調査手法

第2章 アナリストの見解

第3章 組織工学 (ティッシュエンジニアリング) の概要

第4章 世界の組織工学向け医療用品市場の展望

  • 市場規模とその予測
    • 金額ベース
    • 数量ベース
  • 市場シェアとその予測
    • 活用分野別 (整形外科、心血管、歯科、代用皮膚など)
    • 材料別 (合成/天然バイオマテリアル)
    • 地域別
    • 企業別
  • 品質管理ポリシー

第5章 部門別の市場展望

  • 整形外科用・組織工学向け医療用品市場の展望
    • 市場規模とその予測
      • 金額ベース
      • 数量ベース
    • 市場シェアとその予測
      • 製品の種類別 (生物製剤、骨移植片、代用骨移植片)
      • 地域別
      • 企業別
  • 心臓用・組織工学向け医療用品市場の展望
    • 市場規模とその予測
      • 金額ベース
      • 数量ベース
    • 市場シェアとその予測
      • 製品の種類別 (心臓弁、人工血管)
      • 地域別
      • 企業別
  • 歯科用・組織工学向け医療用品市場の展望
    • 市場規模とその予測
      • 金額ベース
      • 数量ベース
    • 市場シェアとその予測
      • 製品の種類別 (歯科用メンブレン、歯科用骨移植片)
      • 地域別
      • 企業別
  • 代用皮膚用・組織工学向け医療用品市場の展望
    • 市場規模とその予測
      • 金額ベース
      • 数量ベース
    • 市場シェアとその予測
      • 製品の種類別 (創傷、火傷など)
      • 地域別
      • 企業別

第6章 地域別の市場展望

  • 北米市場
    • 市場規模とその予測 (金額ベース)
    • 市場シェアとその予測
      • 国別
      • 活用分野別 (整形外科、歯科、代用皮膚など)
  • 欧州市場
  • 南米市場
  • アジア太平洋地域市場
  • 中東・アフリカ市場

第7章 市場のダイナミクス

  • 市場促進要因
  • 市場の課題

第8章 市場の傾向と発展

  • 組織工学におけるナノテクノロジー
  • バイオ用3Dプリンターによる組織工学の進歩
  • 骨向け組織工学での継続的なイノベーション
  • 慢性創傷治癒向けの組織工学の利用拡大
  • 組織工学における改変タンパク質の利用増加
  • 組織工学・バイオマテリアルによる形成外科の革命的変化
  • 組織工学:眼科での将来性
  • 組織工学研究における幹細胞の利用増加

第9章 競争環境

  • 競争力の比較分析
  • 企業プロファイル
    • Medtronic plc
    • Stryker Corporation
    • Zimmer Biomet
    • DePuy Synthes
    • Edwards Lifesciences Corporation
    • Smith & Nephew
    • Geistlich Pharma AG
    • Organogenesis Inc.
    • Institut Straumann AG
    • CryoLife, Inc.
    • Dentsply International
    • Integra LifeSciences Corporation
    • MiMedx Group, Inc.
    • St. Jude Medical, Inc.
    • B. Braun Melsungen AG
    • Wright Medical Technology, Inc.
    • ACE Surgical Supply Company, Inc.
    • BioHorizons IPH, Inc.
    • Botiss Biomaterials GmbH
    • Cytograft Tissue Engineering
    • Molnlycke Health Care
    • TEI Biosciences

第10章 戦略的提言

図表一覧

目次

Tissue engineering involves biomaterial development and practice of combining cells, scaffolds and biologically active molecules into fully functional tissues and organs, for implantation in the living beings. This technology is used for making reconstructive implants that are used for replacing malfunctioned tissues and organs. Tissue engineered medical devices being more bio-compatible in comparison to artificial implants are preferred for treatment surgeries. Moreover, lower probability of rejection by human autoimmune system is also boosting its adoption among the physicians and patients requiring implants.

According to Pharmaion report, "Global Tissue Engineered Medical Devices Market Forecast & Opportunities, 2020 ", global tissue engineered medical devices market is anticipated to surpass US$ 26 billion by 2020 on account of increasing prevalence of diabetes, aging population and increasing demand for tissue engineered medical devices over artificial implants. North America dominated the global tissue engineered medical devices market in 2014, and is anticipated to continue its dominance through 2020 as the percentage of geriatric population is very high in this region. Moreover, the economic stability of the region also helps patients to undergo expensive treatment options. Few of the leading companies operating in global tissue engineered medical devices market include Medtronic plc, Stryker Corporation, Zimmer Biomet, Edwards Lifesciences Corporation and Depuy Synthes, among others. "Global Tissue Engineered Medical Devices Market Forecast & Opportunities, 2020 " report elaborates the following aspects of global tissue engineered medical devices market:

  • Global Tissue Engineered Medical Market Size, Volume, Share & Forecast
  • Segmental Analysis - Orthopedic Tissue, Cardiac Tissue, Dental Tissue & Skin Substitutes
  • Regional Analysis - North America, Europe, South America, Asia-Pacific, and Middle East & Africa
  • Changing Market Trends & Emerging Opportunities
  • Competitive Landscape & Strategic Recommendations

Why You Should Buy This Report?

  • To gain an in-depth understanding of global tissue engineered medical devices market
  • To identify the on-going trends and anticipated growth in the next five years
  • To help industry consultants, tissue engineered medical device manufacturers, vendors and dealers align their market-centric strategies
  • To obtain research based business decisions and add weight to presentations and marketing material
  • To gain competitive knowledge of leading market players
  • To avail 10% customization in the report without any extra charges and get the research data or trends added in the report as per the buyer's specific needs

Report Methodology

The information contained in this report is based upon both primary and secondary sources. Primary researchincluded interviews with tissue engineered medical devices producers and industry experts. Secondary researchincluded an exhaustive search of relevant publications like company annual reports, financial reports and other

Table of Contents

1. Research Methodology

2. Analyst View

3. Tissue Engineering Overview

4. Global Tissue Engineered Medical Devices Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share & Forecast
    • 4.2.1. By Application (Orthopedic, Cardiovascular, Dental, Skin Substitute & Others)
    • 4.2.2. By Source (Synthetic Biomaterials & Natural Biomaterials)
    • 4.2.3. By Region
    • 4.2.4. By Company
  • 4.3. Quality Control Policies

5. Global Tissue Engineered Medical Devices Segmental Market Outlook

  • 5.1. Global Orthopedic Tissue Engineered Medical Devices Market Outlook
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. Market Share & Forecast
      • 5.1.2.1. By Product Type (Biologics, Bone Graft & Bone Graft Substitute)
      • 5.1.2.2. By Region
      • 5.1.2.3. By Company
  • 5.2. Global Cardiac Tissue Engineered Medical Devices Market Outlook
    • 5.2.1. Market Share & Forecast
      • 5.2.1.1. By Value
      • 5.2.1.2. By Volume
    • 5.2.2. Market Share & Forecast
      • 5.2.2.1. By Product Type (Heart Valves & Vascular Grafts)
      • 5.2.2.2. By Region
      • 5.2.2.3. By Company
  • 5.3. Global Dental Tissue Engineered Medical Devices Market Outlook
    • 5.3.1. Market Size & Forecast
      • 5.3.1.1. By Value
      • 5.3.1.2. By Volume
    • 5.3.2. Market Share & Forecast
      • 5.3.2.1. By Product Type (Dental Membrane & Dental Bone Graft)
      • 5.3.2.2. By Region
      • 5.3.2.3. By Company
  • 5.4. Global Skin Substitutes Engineered Medical Devices Market Outlook
    • 5.4.1. Market Size & Forecast
      • 5.4.1.1. By Value
      • 5.4.1.2. By Volume
    • 5.4.2. Market Share & Forecast
      • 5.4.2.1. By Application (Wound, Burn & Others)
      • 5.4.2.2. By Region
      • 5.4.2.3. By Company

6. Global Tissue Engineered Medical Devices Regional Market Outlook

  • 6.1. North America Tissue Engineered Medical Devices Market Outlook
    • 6.1.1. Market Size & Forecast
      • 6.1.1.1. By Value
    • 6.1.2. Market Share & Forecast
      • 6.1.2.1. By Country
      • 6.1.2.2. By Application (Orthopedic, Cardiovascular, Dental, Skin Substitute & Others)
  • 6.2. Europe Tissue Engineered Medical Devices Market Outlook
    • 6.2.1. Market Size & Forecast
      • 6.2.1.1. By Value
    • 6.2.2. Market Share & Forecast
      • 6.2.2.1. By Country
      • 6.2.2.2. By Application (Orthopedic, Cardiovascular, Dental, Skin Substitute & Others)
  • 6.3. South America Tissue Engineered Medical Devices Market Outlook
    • 6.3.1. Market Size & Forecast
      • 6.3.1.1. By Value
    • 6.3.2. Market Share & Forecast
      • 6.3.2.1. By Country
      • 6.3.2.2. By Application (Orthopedic, Cardiovascular, Dental, Skin Substitute & Others)
  • 6.4. Asia-Pacific Tissue Engineered Medical Devices Market Outlook
    • 6.4.1. Market Size & Forecast
      • 6.4.1.1. By Value
    • 6.4.2. Market Share & Forecast
      • 6.4.2.1. By Country
      • 6.4.2.2. By Application (Orthopedic, Cardiovascular, Dental, Skin Substitute & Others)
  • 6.5. Middle East & Africa Tissue Engineered Medical Devices Market Outlook
    • 6.5.1. Market Size & Forecast
      • 6.5.1.1. By Value
    • 6.5.2. Market Share & Forecast
      • 6.5.2.1. By Country
      • 6.5.2.2. By Application (Orthopedic, Cardiovascular, Dental, Skin Substitute & Others)

7. Market Dynamics

  • 7.1. Drivers
  • 7.2. Challenges

8. Market Trends & Developments

  • 8.1. Nanotechnology in Tissue Engineering
  • 8.2. 3D Bioprinting Advancing the Tissue Engineering
  • 8.3. Bone Tissue Engineering Witnessing Continuous Innovation
  • 8.4. Increasing Use of Tissue Engineered for Chronic Wound Healing
  • 8.5. Rising Application of Engineered Protein in Tissue Engineering
  • 8.6. Tissue Engineering and Biomaterials to Revolutionize Plastic Surgery Industry
  • 8.7. Tissue Engineering: Future of Ophthalmology
  • 8.8. Escalating Use of Stem Cells in Tissue Engineering Research

9. Competitive Landscape

  • 9.1. Competition Benchmarking
  • 9.2. Company Profiles
    • 9.2.1. Medtronic plc
    • 9.2.2. Stryker Corporation
    • 9.2.3. Zimmer Biomet
    • 9.2.4. DePuy Synthes
    • 9.2.5. Edwards Lifesciences Corporation
    • 9.2.6. Smith & Nephew
    • 9.2.7. Geistlich Pharma AG
    • 9.2.8. Organogenesis Inc.
    • 9.2.9. Institut Straumann AG
    • 9.2.10. CryoLife, Inc.
    • 9.2.11. Dentsply International
    • 9.2.12. Integra LifeSciences Corporation
    • 9.2.13. MiMedx Group, Inc.
    • 9.2.14. St. Jude Medical, Inc.
    • 9.2.15. B. Braun Melsungen AG
    • 9.2.16. Wright Medical Technology, Inc.
    • 9.2.17. ACE Surgical Supply Company, Inc.
    • 9.2.18. BioHorizons IPH, Inc.
    • 9.2.19. Botiss Biomaterials GmbH
    • 9.2.20. Cytograft Tissue Engineering
    • 9.2.21. Mölnlycke Health Care
    • 9.2.22. TEI Biosciences

10. Strategic Recommendations

List of Figures

  • Figure 1: Global Tissue Engineered Medical Devices Market Size, By Value (USD Billion), By Volume (Million Units), 2010-2020F
  • Figure 2: United States Demand for Kidney Donor, 1990 & 2012
  • Figure 3: Global Tissue Engineered Medical Devices Market Share, By Application, By Value, 2010-2020F
  • Figure 4: Global Tissue Engineered Medical Devices Market Share, By Application, By Volume, 2010-2020F
  • Figure 5: Global Tissue Engineered Medical Devices Market Share, By Source, By Value, 2010-2020F
  • Figure 6: Global Tissue Engineered Medical Devices Market Share, By Region, By Value, 2010-2020F
  • Figure 7: Global Tissue Engineered Medical Devices Market Share, By Company, By Value, 2014 & 2020F
  • Figure 8: Cell Tissue Technology Laboratory's Document Structure
  • Figure 9: Global Orthopedic Tissue Engineered Medical Devices Market Size, By Value (USD Billion), By Volume (Million Units), 2010-2020F
  • Figure 10: Global Orthopedic Tissue Engineered Medical Devices Market Share, By Product Type, By Value, 2010-2020F
  • Figure 11: Global Orthopedic Tissue Engineered Medical Devices Market Share, By Region, By Value, 2010-2020F
  • Figure 12: Global Orthopedic Tissue Engineered Medical Devices Market Share, By Company, By Value, 2014 & 2020F
  • Figure 13: Global Cardiac Tissue Engineered Medical Devices Market Size, By Value (USD Billion), By Volume (Million Units), 2010-2020F
  • Figure 14: Global Cardiac Tissue Engineered Medical Devices Market Share, By Product Type, By Value, 2010-2020F
  • Figure 15: Global Cardiac Tissue Engineered Medical Devices Market Share, By Region, By Value, 2010-2020F
  • Figure 16: Global Cardiac Tissue Engineered Medical Devices Market Share, By Company, By Value, 2014 & 2020F
  • Figure 17: Global Dental Tissue Engineered Medical Devices Market Size, By Value (USD Billion), By Volume (Million Units), 2010-2020F
  • Figure 18: Global Dental Tissue Engineered Medical Devices Market Share, By Product Type, By Value, 2010-2020F
  • Figure 19: Global Dental Tissue Engineered Medical Devices Market Share, By Region, By Value, 2010-2020F
  • Figure 20: Global Dental Tissue Engineered Medical Devices Market Share, By Company, By Value, 2014 & 2020F
  • Figure 21: Global Skin Substitute Tissue Engineered Medical Devices Market Size, By Value (USD Billion), By Volume (Million Units), 2010-2020F
  • Figure 22: Global Skin Substitute Tissue Engineered Medical Devices Market Share, By Application, By Value, 2010-2020F
  • Figure 23: United States Statistics of Burn Injuries, 2013
  • Figure 24: Global Skin Substitute Tissue Engineered Medical Devices Market Share, By Region, By Value, 2010-2020F
  • Figure 25: Global Skin Substitute Tissue Engineered Medical Devices Market Share, By Company, By Value, 2014 & 2020F
  • Figure 26: North America Tissue Engineered Medical Devices Market Size, By Value (USD Billion), 2010-2020F
  • Figure 27: North America Tissue Engineered Medical Devices Market Share, By Country, By Value, 2010-2020F
  • Figure 28: United States Prevalence of Cardiovascular Disease in Adults above 20 years of Age, By Age, By Sex, 2015 (% of total population)
  • Figure 29: United States Percentage Breakdown of Deaths due to Cardiovascular Disease, 2011
  • Figure 30: North America Tissue Engineered Medical Devices Market Share, By Application, By Value, 2010-2020F
  • Figure 31: Europe Tissue Engineered Medical Devices Market Size, By Value (USD Billion), 2010-2020F
  • Figure 32: Europe Tissue Engineered Medical Devices Market Share, By Country, By Value, 2010-2020F
  • Figure 33: Europe Tissue Engineered Medical Devices Market Share, By Application, By Value, 2010-2020F
  • Figure 34: South America Tissue Engineered Medical Devices Market Size, By Value (USD Billion), 2010-2020F
  • Figure 35: South America Tissue Engineered Medical Devices Market Share, By Country, By Value, 2010-2020F
  • Figure 36: South America Tissue Engineered Medical Devices Market Share, By Application, By Value, 2010-2020F
  • Figure 37: Asia-Pacific Tissue Engineered Medical Devices Market Size, By Value (USD Billion), 2010-2020F
  • Figure 38: Asia-Pacific Tissue Engineered Medical Devices Market Share, By Country, By Value, 2010-2020F
  • Figure 39: Asia-Pacific Tissue Engineered Medical Devices Market Share, By Application, By Value, 2010-2020F
  • Figure 40: Middle East & Africa Tissue Engineered Medical Devices Market Size, By Value (USD Billion), 2010-2020F
  • Figure 41: Middle East & Africa Tissue Engineered Medical Devices Market Share, By Country, By Value, 2010-2020F
  • Figure 42: Middle East & Africa Tissue Engineered Medical Devices Market Share, By Application, By Value, 2010-2020F
  • Figure 43: Percentage of Natural Sources Used for Synthesis of Nanoparticles
  • Figure 44: Percentage of Plant and Animal Based Materials Used for Synthesis of Nanoparticles
  • Figure 45: Global 3D Printing Market Size, By Value (USD Million), 2010-2020F
  • Figure 46: Global Bone Graft Market Size, By Value (USD Million), 2010-2020F
  • Figure 47: Global Tissue Engineered Skin Substitute for Wound Healing Market Size, By Value (USD Million), 2010-2020F
  • Figure 48: Worldwide Wound Incidence, 2014
  • Figure 49: Global Protein Engineering Market Size, By Value, 2010-2020F (USD Million)

List of Tables

  • Table 1: Global Tissue Engineered Medical Devices Market Size, By Source (USD Million)
  • Table 2: Number of Diabetic Patients, By Country, 2013 (Million)
  • Table 3: United States Statistics of Gum Diseases, 2012
  • Table 4: Global Prevalence of Diabetes, 2012
  • Table 5: Canada Population Projections for Over 65 Years of Age, 1971 - 2061F (%)
  • Table 6: Middle East Healthcare Expenditure, 2010
Back to Top